logo

Ardelyx, Inc (ARDX)



Trade ARDX now with
  Date
  Headline
10/8/2018 8:08:46 AM Ardelyx Showcases New Data From T3MPO-3 Long-Term Safety Trial Of Tenapanor For IBS-C In Presidential Poster At ACG
9/13/2018 6:34:01 AM Ardelyx Submits NDA For U.S. Marketing Authorization Of Tenapanor For IBS-C To FDA
5/21/2018 4:03:17 PM Ardelyx Announces Proposed Public Offering Of Common Stock
5/9/2018 7:18:09 AM Wedbush Is Cutting Ardelyx, Inc (ARDX) FY18 Estimate To -1.70 From -1.61
5/9/2018 7:17:54 AM Wedbush Is Lowering Ardelyx, Inc (ARDX) Q4 18 Estimate To -0.47 From -0.40
5/9/2018 7:17:41 AM Wedbush Is Cutting Ardelyx, Inc (ARDX) Q3 18 Estimate To -0.45 From -0.42
5/9/2018 7:17:21 AM Wedbush Is Cutting Ardelyx, Inc (ARDX) Q2 18 Estimate To -0.43 From -0.40
3/19/2018 6:35:14 AM Ardelyx And Knight Collaborate To Bring Tenapanor To Patients In Canada
3/15/2018 2:04:42 PM Wedbush Is Lowering Ardelyx, Inc (ARDX) 2018 Estimate To -1.61 From -0.88
3/15/2018 2:04:25 PM Wedbush Is Cutting Ardelyx, Inc (ARDX) 4Q18 Estimate To -0.40 From -0.24
3/15/2018 2:04:11 PM Wedbush Is Lowering Ardelyx, Inc (ARDX) 3Q18 Estimate To -0.42 From -0.23
3/15/2018 2:03:54 PM Wedbush Is Cutting Ardelyx, Inc (ARDX) 2Q18 Estimate To -0.40 From -0.21
3/15/2018 2:03:39 PM Wedbush Is Lowering Ardelyx, Inc (ARDX) 1Q18 Estimate To -0.39 From -0.20
3/15/2018 2:03:10 PM Wedbush Is Cutting Ardelyx, Inc (ARDX) 2018 Rev. Estimate To 0.0 M From 24.0 M
3/15/2018 2:02:54 PM Wedbush Is Lowering Ardelyx, Inc (ARDX) 4Q18 Rev. Estimate To 0.0 M From 6.0 M
3/15/2018 2:02:44 PM Wedbush Is Lowering Ardelyx, Inc (ARDX) 3Q18 Rev. Estimate To 0.0 M From 6.0 M
3/15/2018 2:02:33 PM Wedbush Is Lowering Ardelyx, Inc (ARDX) 2Q18 Rev. Estimate To 0.0 M From 6.0 M
3/15/2018 2:02:21 PM Wedbush Is Lowering Ardelyx, Inc (ARDX) 1Q18 Rev. Estimate To 0.0 M From 6.0 M
2/12/2018 6:31:27 AM Ardelyx: Jeremy Caldwell, Chief Scientific Officer, To Be Leaving